Journal articles: 'And metabolically normal obese'

1

Kelishadi, Roya, Stephen R. Cook, Mohammad Esmaeil Motlagh, et al. "Metabolically Obese Normal Weight and Phenotypically Obese Metabolically Normal Youths: The CASPIAN Study." Journal of the American Dietetic Association 108, no. 1 (2008): 82–90. http://dx.doi.org/10.1016/j.jada.2007.10.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Guerrero-Romero, Fernando. "Metabolically obese normal-weight children." World Journal of Clinical Pediatrics 1, no. 4 (2012): 37. http://dx.doi.org/10.5409/wjcp.v1.i4.37.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Teixeira, T. F., R. D. Alves, A. P. B. Moreira, and M. d. C. G. Peluzio. "Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes." Nutrition Reviews 73, no. 3 (2015): 175–90. http://dx.doi.org/10.1093/nutrit/nuu007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Wu, Shenghui, Susan P. Fisher-Hoch, Belinda Reninger, Kristina Vatcheva, and Joseph B. McCormick. "Metabolic Health Has Greater Impact on Diabetes than Simple Overweight/Obesity in Mexican Americans." Journal of Diabetes Research 2016 (2016): 1–9. http://dx.doi.org/10.1155/2016/4094876.

Full text

Abstract:

Purpose. To compare the risk for diabetes in each of 4 categories of metabolic health and BMI.Methods. Participants were drawn from the Cameron County Hispanic Cohort, a randomly selected Mexican American cohort in Texas on the US-Mexico border. Subjects were divided into 4 phenotypes according to metabolic health and BMI: metabolically healthy normal weight, metabolically healthy overweight/obese, metabolically unhealthy normal weight, and metabolically unhealthy overweight/obese. Metabolic health was defined as having less than 2 metabolic abnormalities. Overweight/obese status was assessed by BMI higher than 25 kg/m2. Diabetes was defined by the 2010 ADA definition or by being on a diabetic medication.Results. The odds ratio for diabetes risk was 2.25 in the metabolically healthy overweight/obese phenotype (95% CI 1.34, 3.79), 3.78 (1.57, 9.09) in the metabolically unhealthy normal weight phenotype, and 5.39 (3.16, 9.20) in metabolically unhealthy overweight/obese phenotype after adjusting for confounding factors compared with the metabolically healthy normal weight phenotype.Conclusions. Metabolic health had a greater effect on the increased risk for diabetes than overweight/obesity. Greater focus on metabolic health might be a more effective target for prevention and control of diabetes than emphasis on weight loss alone.

APA, Harvard, Vancouver, ISO, and other styles

5

Kaur, Akaal, Desmond G. Johnston, and Ian F. Godsland. "Does metabolic health in overweight and obesity persist? – Individual variation and cardiovascular mortality over two decades." European Journal of Endocrinology 175, no. 2 (2016): 133–43. http://dx.doi.org/10.1530/eje-16-0095.

Full text

Abstract:

Objective Overweight and obese individuals may be metabolically healthy, but attention needs to be given to long-term persistence of this trait and any associated variation in cardiovascular risk. Design Cross-sectional and longitudinal variation in metabolic health and associated cardiovascular mortality were analysed in 1099 white European-origin normal-weight and overweight or obese males followed for 20years. Methods Definitions of metabolic health were based on LDL and HDL cholesterol, triglycerides, blood pressure, fasting glucose and cardiovascular risk. Insulin resistance (e.g. HOMA-IR) and sub-clinical inflammation (ESR and white blood cell count) were explored. Cardiovascular mortality risks and persistence of metabolic health status were evaluated. Results There were 87 cardiovascular deaths. Insulin resistance was increased in metabolically healthy overweight or obese participants (median HOMA-IR 2.63, 95% CI: 1.79–3.65, P<0.001) relative to normal-weight participants (median HOMA-IR 1.67, 95% CI: 1.08–2.67, P<0.001) as was sub-clinical inflammation but metabolically healthy overweight or obese individuals were not at increased risk of cardiovascular mortality compared with the metabolically healthy normal-weight individuals (hazard ratio 1.13, 95% CI: 0.34–3.72, P=0.8). The proportions of initially metabolically healthy overweight or obese who remained metabolically healthy for visits 2, 3 and 4 were 54, 48 and 39% respectively, and for initially normal-weight individuals, 68, 51 and 41%. A lower proportion of metabolically healthy overweight or obese individuals remained metabolically healthy at visit 2 compared with normal-weight individuals (P=0.007), but proportions converged thereafter. Conclusions Despite being insulin resistant and having greater sub-clinical inflammation, and despite instability in metabolic health status, metabolically healthy overweight or obese individuals were at no greater risk of cardiovascular mortality than their normal-weight equivalents.

APA, Harvard, Vancouver, ISO, and other styles

6

Gómez-Zorita, Saioa, Maite Queralt, Maria Angeles Vicente, Marcela González, and María P. Portillo. "Metabolically healthy obesity and metabolically obese normal weight: a review." Journal of Physiology and Biochemistry 77, no. 1 (2021): 175–89. http://dx.doi.org/10.1007/s13105-020-00781-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Naher, Sabikun, M. Mozammel Hoque, and Hasan Imam. "Obesity phenotypes and their adipocyte dysfunction among the attendants at outpatient department." Bangabandhu Sheikh Mujib Medical University Journal 11, no. 2 (2018): 112. http://dx.doi.org/10.3329/bsmmuj.v11i2.36507.

Full text

Abstract:

<p>The present study was aimed to find out the frequency of obesity phenotypes and to correlate adipocyte dysfunction with different obesity phenotypes. A total of 1,507 apparently healthy adults attending the outpatient department were grouped into three based on body mass index which were then further categorized into six groups according to metabolically unhealthy or healthy phenotypes by the presence or absence of metabolic syndrome. Of them, metabolically obese normal weight, overweight, healthy obese and unhealthy obese groups were included as obesity phenotypes. Then by purposive sampling, leptin and adiponectin concentration of 184 subjects with different phenotypes were measured to find out the adipocyte dysfunction. Metabolically obese overweight followed by metabolically unhealthy obese were more prevalent i,e., 24.9% and 19.5%. All obesity phenotypes except metabolically obese normal weight were significantly documented with adipocyte dysfunction (p&lt;0.05).</p>

APA, Harvard, Vancouver, ISO, and other styles

8

Ruderman, N., D. Chisholm, X. Pi-Sunyer, and S. Schneider. "The metabolically obese, normal-weight individual revisited." Diabetes 47, no. 5 (1998): 699–713. http://dx.doi.org/10.2337/diabetes.47.5.699.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Succurro, Elena, Maria A. Marini, Simona Frontoni, et al. "Insulin Secretion in Metabolically Obese, but Normal Weight, and in Metabolically Healthy but Obese Individuals." Obesity 16, no. 8 (2008): 1881–86. http://dx.doi.org/10.1038/oby.2008.308.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

BEDDAR, Lamia, Abdelmadjid CHAA, and Akila ZENATI. "Prevalence of metabolically obese normal weight population in adolescent." Nutrition & Santé 04, no. 02 (2015): 62–68. http://dx.doi.org/10.30952/ns.4.2.4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Bertran, Laia, Jordi Capellades, Sonia Abelló, Carmen Aguilar, Teresa Auguet, and Cristóbal Richart. "Untargeted lipidomics analysis in women with morbid obesity and type 2 diabetes mellitus: A comprehensive study." PLOS ONE 19, no. 5 (2024): e0303569. http://dx.doi.org/10.1371/journal.pone.0303569.

Full text

Abstract:

There is a phenotype of obese individuals termed metabolically healthy obese that present a reduced cardiometabolic risk. This phenotype offers a valuable model for investigating the mechanisms connecting obesity and metabolic alterations such as Type 2 Diabetes Mellitus (T2DM). Previously, in an untargeted metabolomics analysis in a cohort of morbidly obese women, we observed a different lipid metabolite pattern between metabolically healthy morbid obese individuals and those with associated T2DM. To validate these findings, we have performed a complementary study of lipidomics. In this study, we assessed a liquid chromatography coupled to a mass spectrometer untargeted lipidomic analysis on serum samples from 209 women, 73 normal-weight women (control group) and 136 morbid obese women. From those, 65 metabolically healthy morbid obese and 71 with associated T2DM. In this work, we find elevated levels of ceramides, sphingomyelins, diacyl and triacylglycerols, fatty acids, and phosphoethanolamines in morbid obese vs normal weight. Conversely, decreased levels of acylcarnitines, bile acids, lyso-phosphatidylcholines, phosphatidylcholines (PC), phosphatidylinositols, and phosphoethanolamine PE (O-38:4) were noted. Furthermore, comparing morbid obese women with T2DM vs metabolically healthy MO, a distinct lipid profile emerged, featuring increased levels of metabolites: deoxycholic acid, diacylglycerol DG (36:2), triacylglycerols, phosphatidylcholines, phosphoethanolamines, phosphatidylinositols, and lyso-phosphatidylinositol LPI (16:0). To conclude, analysing both comparatives, we observed decreased levels of deoxycholic acid, PC (34:3), and PE (O-38:4) in morbid obese women vs normal-weight. Conversely, we found elevated levels of these lipids in morbid obese women with T2DM vs metabolically healthy MO. These profiles of metabolites could be explored for the research as potential markers of metabolic risk of T2DM in morbid obese women.

APA, Harvard, Vancouver, ISO, and other styles

12

Jakubiak, Grzegorz K., Kamila Osadnik, Mateusz Lejawa, Sławomir Kasperczyk, Tadeusz Osadnik, and Natalia Pawlas. "Oxidative Stress in Association with Metabolic Health and Obesity in Young Adults." Oxidative Medicine and Cellular Longevity 2021 (June 26, 2021): 1–19. http://dx.doi.org/10.1155/2021/9987352.

Full text

Abstract:

Introduction. Obesity is one of the most important public health problems in the world. Among obese people, there are those who, apart from excessive body weight, do not exhibit other metabolic dysfunctions, have a lower risk of developing cardiovascular diseases (CVDs), and show lower mortality. According to the theory, they are referred as metabolically healthy obese (MHO), in contrast to metabolically unhealthy obese (MUO). Metabolic disturbances occurring with obesity have been well established to be associated with oxidative stress. Aim. The purpose of this study was to analyse the association between selected anthropometric and biochemical parameters with oxidative stress in MHO, MUO, and normal weight young adults. Material and Methods. Individuals with age between 18 and 36 years with no history of chronic diseases and use of medicaments, with or without obesity, participated in the study. Complete blood counts, biochemical measurements, and parameters of oxidative stress such as total antioxidant capacity (TAC), total oxidative status (TOS), oxidative stress index (OSI), serum concentration of malondialdehyde (MDA), ceruloplasmin, thiol groups and lipid hydroperoxides (LPH), concentration of lipofuscin (LPS) in erythrocytes, and the activity of superoxide dismutase (SOD) were measured. Results. 422 patients who met the inclusion criteria were enrolled in the study. Among the study participants, 208 people (49.29%) were offspring of patients with angiographically confirmed coronary artery disease. Among the participants, 16 patients have been included in the group of metabolically healthy obese (MHO) people and 61 patients in the group of metabolically unhealthy obese (MUO) people and 345 patients had normal body weight. Significant differences between metabolically unhealthy obese and normal weight patients, as well as between women and men, have been found. Conclusions. We showed significant differences in the selected parameters of oxidative stress between metabolically unhealthy obese (MUO) individuals and young volunteers with normal body weight as well as without significant medical history.

APA, Harvard, Vancouver, ISO, and other styles

13

Bershteĭn, L. M., and I. G. Kovalenko. "Metabolically healthy obese subjects and metabolic signs of obesity in subjects with normal body weight: what is behind?" Problems of Endocrinology 56, no. 3 (2010): 47–51. http://dx.doi.org/10.14341/probl201056347-51.

Full text

Abstract:

The current concept of obesity as a heterogeneous condition is discussed. Such interpretation provides a basis for distinguishing a group of obese subjects without metabolic disturbances (metabolically healthy obese (MHO) subjects) and another one including subjects with normal body weight and signs of hormonal and metabolic disorders (metabolically obese normal weight (MONW) subjects). A separate subgroup is represented by obese patients with deficit of muscular mass and force (sarcopenic obesity). Potential mechanisms underlying development of these conditions are considered along with selected applied aspects of this problem.

APA, Harvard, Vancouver, ISO, and other styles

14

Huang, Lam O., Ruth J. F. Loos, and Tuomas O. Kilpeläinen. "Evidence of genetic predisposition for metabolically healthy obesity and metabolically obese normal weight." Physiological Genomics 50, no. 3 (2018): 169–78. http://dx.doi.org/10.1152/physiolgenomics.00044.2017.

Full text

Abstract:

Obesity has evolved into a global pandemic that constitutes a major threat to public health. The majority of obesity-related health care costs are due to cardiometabolic complications, such as insulin resistance, dyslipidemia, and hypertension, which are risk factors for Type 2 diabetes and cardiovascular disease. However, many obese individuals, often called metabolically healthy obese (MHO), seem to be protected from these cardiometabolic complications. Conversely, there is a group of individuals who suffer from cardiometabolic complications despite being of normal weight; a condition termed metabolically obese normal weight (MONW). Recent large-scale genomic studies have provided evidence that a number of genetic variants show an association with increased adiposity but a favorable cardiometabolic profile, an indicator for the genetic basis of the MHO and MONW phenotypes. Many of these loci are located in or near genes that implicate pathways involved in adipogenesis, fat distribution, insulin signaling, and insulin resistance. It has been suggested that a threshold for subcutaneous adipose tissue expandability may be at play in the manifestation of MHO and MONW, where expiry of adipose tissue storage capacity could lead to ectopic lipid accumulation in non-adipose tissues such as liver, muscle, heart, and pancreatic beta cells. Understanding the genetic aspects of the mechanisms that underpin MHO and MONW is crucial to define appropriate public health action points and to develop effective intervention measures.

APA, Harvard, Vancouver, ISO, and other styles

15

Naher, S., SS Sejooti, MM Hoque, et al. "Metabolic Phenotyping Using Metabolic Syndrome Criteria and Cardiometabolic Disabilities Criteria in Bangladeshi Adult Population." Bangladesh Journal of Medical Biochemistry 11, no. 1 (2019): 1–8. http://dx.doi.org/10.3329/bjmb.v11i1.39762.

Full text

Abstract:

Obesity has become a global epidemic and has been found to be associated with numerous comorbidities. Body mass index (BMI) based classification of obesity is simple but co-morbidities do not affect all obese and overweight people. The present study was aimed to find out the frequency of metabolic phenotypes in different BMI groups using metabolic syndrome (MetS) criteria and cardiometabolic disabilities (CA) criteria and also to find out an appropriate method for defining metabolic health among adult population attending out patient department of Bangabandhu Sheikh Mujib Medical University (BSMMU). This cross-sectional analytical study was carried out in the Department of Biochemistry, Bangabandhu Sheikh Mujib Medical University (BSMMU) from March 2016 to February 2017. By non probability sampling, a total of 1023 study subjects were selected from apparently healthy adult individuals attending outpatient department of BSMMU. The study subjects were grouped into three body mass index classes and also further categorized into six groups according to metabolically unhealthy or healthy phenotypes by presence or absence of metabolic syndrome (MetS) criteria as well as cardiometabolic disabilities (CA) criteria respectively. Then agreement among different metabolic phenotypes based on these two criteria were observed. Frequency of different metabolic phenotypes i,e metabolically healthy normal weight (MHNW), metabolically obese normal weight (MONW), metabolically healthy over weight (MHOW), metabolically obese over weight (MOOW), metabolically healthy obese (MHO) and metabolically unhealthy obese (MUO) were 12.3%, 6.9%, 21.4%, 27.7%, 7.7%, 23.9% by MetS criteria and 7.7%, 11.5%, 11.6%, 37.4%, 6.1%, 25.6% by CA criteria respectively. MOOW followed by MUO were found to be predominant among all phenotypes. Fare agreement was found between two criteria in case of normal weight and overweight groups and good agreement was found in case of obese groups. From this study, it may be concluded that, attention should be given to the metabolically obese phenotypes in different BMI classes to reduce co-morbidities. Bangladesh J Med Biochem 2018; 11(1): 1-8

APA, Harvard, Vancouver, ISO, and other styles

16

Conus, Florence, Rémi Rabasa-Lhoret, and François Péronnet. "Characteristics of metabolically obese normal-weight (MONW) subjects." Applied Physiology, Nutrition, and Metabolism 32, no. 1 (2007): 4–12. http://dx.doi.org/10.1139/h06-092.

Full text

Abstract:

The existence of a subgroup of normal-weight individuals displaying obesity-related phenotypic characteristics was first proposed in 1981. These individuals were identified as metabolically obese but normal weight (MONW). It was hypothesized that these individuals might be characterized by hyperinsulinemia and (or) insulin resistance, as well as by hypertriglyceridemia and high blood pressure despite having a body mass index (BMI) < 25 kg/m2. Such characteristics could confer upon MONW subjects a higher cardiovascular risk; however, scientific data on MONW subjects are scarce since only 9 publications are directly related to this topic. Despite differences in the criteria for identifying MONW subjects and the small number of subjects involved in most of these studies, their consistent results indicate that: (i) the prevalence of the MONW syndrome ranges between 5% and 45%, depending on the criteria used, age, BMI, and ethnicity; (ii) when compared with control subjects, MONW subjects display an altered insulin sensitivity, a higher abdominal and visceral adiposity, a more atherogenic lipid profile, a higher blood pressure, and a lower physical activity energy expenditure; and (iii) MONW subjects are at higher risks for type 2 diabetes and cardiovascular diseases.

APA, Harvard, Vancouver, ISO, and other styles

17

Jung, Younhea, Gyoung Nyun Kim, Eun Byeol Oh, Kyoung Ohn, and Jung Il Moon. "Metabolic Health, Obesity, and Intraocular Pressure." Journal of Clinical Medicine 12, no. 5 (2023): 2066. http://dx.doi.org/10.3390/jcm12052066.

Full text

Abstract:

Obesity has been associated with increased intraocular pressure (IOP), but the results are inconsistent. Recently, a subgroup of obese individuals with good metabolic profiles were suggested to have better clinical outcomes than normal-weight individuals with metabolic diseases. The relationships between IOP and different combinations of obesity and metabolic health status have not been investigated. Therefore, we investigated the IOP among groups with different combinations of obesity status and metabolic health status. We examined 20,385 adults aged 19 to 85 years at the Health Promotion Center of Seoul St. Mary’s Hospital between May 2015 and April 2016. Individuals were categorized into four groups according to obesity (body mass index (BMI) ≥ 25 kg/m2) and metabolic health status (defined based on prior medical history or abdominal obesity, dyslipidemia, low high-density lipoprotein cholesterol, high blood pressure, or high fasting blood glucose levels upon medical examination). ANOVA and ANCOVA were performed to compare the IOP among the subgroups. The IOP of the metabolically unhealthy obese group (14.38 ± 0.06 mmHg) was the highest, followed by that of the metabolically unhealthy normal-weight group (MUNW, 14.22 ± 0.08 mmHg), then, the metabolically healthy groups (p < 0.001; 13.50 ± 0.05 mmHg and 13.06 ± 0.03 mmHg in the metabolically healthy obese (MHO) and metabolically healthy normal-weight groups, respectively). Subjects who were metabolically unhealthy showed higher IOP compared to their counterparts who were metabolically healthy at all BMI levels, and there was a linear increase in IOP as the number of metabolic disease components increased, but no difference between normal-weight vs. obese individuals. While obesity, metabolic health status, and each component of metabolic disease were associated with higher IOP, those who were MUNW showed higher IOP than those who were MHO, which indicates that metabolic status has a greater impact than obesity on IOP.

APA, Harvard, Vancouver, ISO, and other styles

18

Choi, Kyung Mook, Hyun Joo Cho, Hae Yoon Choi, et al. "Higher mortality in metabolically obese normal-weight people than in metabolically healthy obese subjects in elderly Koreans." Clinical Endocrinology 79, no. 3 (2013): 364–70. http://dx.doi.org/10.1111/cen.12154.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Wang, B., R. Zhuang, X. Luo, et al. "Prevalence of Metabolically Healthy Obese and Metabolically Obese but Normal Weight in Adults Worldwide: A Meta-Analysis." Hormone and Metabolic Research 47, no. 11 (2015): 839–45. http://dx.doi.org/10.1055/s-0035-1559767.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Shaharyar, Sameer, Lara L. Roberson, Omar Jamal, et al. "Obesity and Metabolic Phenotypes (Metabolically Healthy and Unhealthy Variants) Are Significantly Associated with Prevalence of Elevated C-Reactive Protein and Hepatic Steatosis in a Large Healthy Brazilian Population." Journal of Obesity 2015 (2015): 1–6. http://dx.doi.org/10.1155/2015/178526.

Full text

Abstract:

Background. Among the obese, the so-called metabolically healthy obese (MHO) phenotype is thought to confer a lower CVD risk as compared to obesity with typical associated metabolic changes. The present study aims to determine the relationship of different subtypes of obesity with inflammatory-cardiometabolic abnormalities.Methods. We evaluated 5,519 healthy, Brazilian subjects (43±10years, 78% males), free of known cardiovascular disease. Those with <2 metabolic risk factors (MRF) were considered metabolically healthy, and those with BMI ≥ 25 kg/m2and/or waist circumference meeting NCEP criteria for metabolic syndrome as overweight/obese (OW). High sensitivity C reactive protein (hsCRP) was measured to assess underlying inflammation and hepatic steatosis (HS) was determined via abdominal ultrasound.Results. Overall, 40% of OW individuals were metabolically healthy, and 12% normal-weight had ≥2 MRF. The prevalence of elevated CRP (≥3 mg/dL) and HS in MHO versus normal weight metabolically healthy group was 22% versus 12%, and 40% versus 8% respectively (P<0.001). Both MHO individuals and metabolically unhealthy normal weight (MUNW) phenotypes were associated with elevated hsCRP and HS.Conclusion. Our study suggests that MHO and MUNW phenotypes may not be benign and physicians should strive to treat individuals in these subgroups to reverse these conditions.

APA, Harvard, Vancouver, ISO, and other styles

21

Guerrero-Romero, Fernando, and Martha Rodriguez-Moran. "Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects." European Journal of Internal Medicine 24, no. 7 (2013): 639–43. http://dx.doi.org/10.1016/j.ejim.2013.02.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Bermudez, Valmore, Joselyn Rojas, Juan Salazar, et al. "Biochemical and clinical characterization of metabolic phenotypes: a cross-sectional study from Maracaibo city, Venezuela." F1000Research 7 (March 24, 2021): 230. http://dx.doi.org/10.12688/f1000research.13897.3.

Full text

Abstract:

Background: In 1980, Reuben Andresen observed that in certain individuals, obesity did not increase mortality, introducing an atypical phenotype called “healthy obese”. Other studies reported that 10-15 % of lean individuals presented insulin resistance, hyperglycemia and dyslipidemia. The objective of this study was to evaluate biochemical and clinical characteristics of metabolic phenotypes in Maracaibo city. Methods: A descriptive, cross-sectional sub-analysis of The Maracaibo City Metabolic Syndrome Prevalence Study, with a randomized multistage sampling was performed including 1226 non diabetic individuals from both sexes. For phenotype definition, the subjects were first classified according to their BMI into Normal-Weight, Overweight and Obese; then divided in metabolically healthy and unhealthy using a two-step analysis cluster being predictive variables: HOMA2-IR, HOMA2-βcell, triglycerides. To evaluate the relationship with coronary risk, a multiple logistic regression model was performed. Results: In the studied population, 43.9% (n=538) were healthy normal weight, 5.2% (n=64) unhealthy normal weight, 17.4% (n=217) healthy obese and 33.5% (n=411) unhealthy obese subjects. Atypical phenotypes, Metabolically Unhealthy Normal-Weight (MUNW) was more frequent in males (56.3%), whereas Metabolically Unhealthy Obese (MUO) was more frequent in females (51.3%). This phenotypes had a higher coronary event risk, especially for obese individuals (MHO: OR=1.85 CI95%: 1.11-3.09; p=0.02 and MUO: OR=2.09 CI95%: 1.34-3.28; p<0.01). Conclusion: Individuals with atypical metabolic phenotypes are common in Maracaibo city. Related factors may include insulin resistance, basal glucose, and triglycerides levels. Lastly, obese subjects show a higher coronary event risk even those with normal metabolic status.

APA, Harvard, Vancouver, ISO, and other styles

23

Bermudez, Valmore, Joselyn Rojas, Juan Salazar, et al. "Biochemical and clinical characterization of metabolic phenotypes: a cross-sectional study from Maracaibo city, Venezuela." F1000Research 7 (January 4, 2019): 230. http://dx.doi.org/10.12688/f1000research.13897.2.

Full text

Abstract:

Background: In 1980, Reuben Andresen observed that in certain individuals, obesity did not increase mortality, introducing an atypical phenotype called “healthy obese”. Other studies reported that 10-15 % of lean individuals presented insulin resistance, hyperglycemia and dyslipidemia. The objective of this study was to evaluate biochemical and clinical characteristics of metabolic phenotypes in Maracaibo city. Methods: A descriptive, cross-sectional sub-analysis of The Maracaibo City Metabolic Syndrome Prevalence Study, with a randomized multistage sampling was performed including 1226 non diabetic individuals from both sexes. For phenotype definition, the subjects were first classified according to their BMI into Normal-Weight, Overweight and Obese; then divided in metabolically healthy and unhealthy using a two-step analysis cluster being predictive variables: HOMA2-IR, HOMA2-βcell, triglycerides. To evaluate the relationship with coronary risk, a multiple logistic regression model was performed. Results: In the studied population, 43.9% (n=538) were healthy normal weight, 5.2% (n=64) unhealthy normal weight, 17.4% (n=217) healthy obese and 33.5% (n=411) unhealthy obese subjects. Atypical phenotypes, Metabolically Unhealthy Normal-Weight (MUNW) was more frequent in males (56.3%), whereas Metabolically Unhealthy Obese (MUO) was more frequent in females (51.3%). This phenotypes had a higher coronary event risk, especially for obese individuals (MHO: OR=1.85 CI95%: 1.11-3.09; p=0.02 and MUO: OR=2.09 CI95%: 1.34-3.28; p<0.01). Conclusion: Individuals with atypical metabolic phenotypes are common in Maracaibo city. Related factors may include insulin resistance, basal glucose, and triglycerides levels. Lastly, obese subjects show a higher coronary event risk even those with normal metabolic status.

APA, Harvard, Vancouver, ISO, and other styles

24

Buscemi, Silvio, Pierfilippo Chiarello, Carola Buscemi, et al. "Characterization of Metabolically Healthy Obese People and Metabolically Unhealthy Normal-Weight People in a General Population Cohort of the ABCD Study." Journal of Diabetes Research 2017 (2017): 1–9. http://dx.doi.org/10.1155/2017/9294038.

Full text

Abstract:

There is actually no consensus about the possibility that in some instances, obesity may be a benign metabolically healthy (MH) condition as opposed to a normal-weight but metabolically unhealthy (MUH) state. The aim of this study was to characterize MH condition and to investigate possible associations with metabolic and cardiovascular complications. One thousand nineteen people (range of age 18–90 years) of the cohort of the ABCD_2 study were investigated. Participants were classified as normal weight (BMI < 24.9 kg/m2) or overweight-obese (BMI ≥25 kg/m2); they were also classified as MH in the presence of 0-1 among the following conditions: (a) prediabetes/type 2 diabetes, (b) hypertension, (c) hypertriglyceridemia or low HDL cholesterolemia, and (d) hypercholesterolemia. MUH condition was diagnosed if ≥2 of the conditions listed were found. The prevalence of overweight/obese people was 71.1%, of whom 27.4% were found to be MH. In addition, 36.7% of the normal-weight participants were MUH. HOMA-IR, high sensitivity C-reactive protein, and the carotid intima-media thickness were significantly different in the 4 subgroups (P<0.001), with higher values observed in the MUH normal-weight and obese groups. In conclusion, this study highlights the importance of identifying a MH condition in normal-weight and in obese people in order to offer better treatment.

APA, Harvard, Vancouver, ISO, and other styles

25

Makoundou, Vincent, Zoltan Pataky, Elisabetha Bobbioni-Harsch, Jean Pierre Gachoud, and Alain Golay. "Do Obese Patients after Weight Loss Become Metabolically Normal?" Obesity Facts 4, no. 3 (2011): 218–21. http://dx.doi.org/10.1159/000329579.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Lejawa, Mateusz, Kamila Osadnik, Zenon Czuba, Tadeusz Osadnik, and Natalia Pawlas. "Association of Metabolically Healthy and Unhealthy Obesity Phenotype with Markers Related to Obesity, Diabetes among Young, Healthy Adult Men. Analysis of MAGNETIC Study." Life 11, no. 12 (2021): 1350. http://dx.doi.org/10.3390/life11121350.

Full text

Abstract:

Adipose tissue secretes many regulatory factors called adipokines. Adipokines affect the metabolism of lipids and carbohydrates. They also influence the regulation of the immune system and inflammation. The current study aimed to evaluate the association between markers related to obesity, diabesity and adipokines and metabolically healthy and unhealthy obesity in young men. The study included 98 healthy participants. We divided participants into three subgroups based on body mass index and metabolic health definition: 49 metabolically healthy normal-weight patients, 27 metabolically healthy obese patients and 22 metabolically unhealthy obese patients. The 14 metabolic markers selected were measured in serum or plasma. The analysis showed associations between markers related to obesity, diabesity and adipokines in metabolically healthy and unhealthy obese participants. The decreased level of adipsin (p < 0.05) was only associated with metabolically healthy obesity, not with metabolically unhealthy obesity. The decreased level of ghrelin (p < 0.001) and increased level of plasminogen activator inhibitor-1 (p < 0.01) were only associated with metabolically unhealthy obesity, not with metabolically healthy obesity. The decreased level of adiponectin and increased levels of leptin, c-peptide, insulin and angiopoietin-like 3 protein were associated with metabolically healthy and unhealthy obesity. In conclusion, our data show that metabolically healthy obesity was more similar to metabolically unhealthy obesity in terms of the analyzed markers related to obesity and diabesity.

APA, Harvard, Vancouver, ISO, and other styles

27

Palatini, Paolo, Agostino Virdis, Stefano Masi, et al. "Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk." Diagnostics 14, no. 13 (2024): 1314. http://dx.doi.org/10.3390/diagnostics14131314.

Full text

Abstract:

The objective of this study was to investigate the longitudinal association of metabolically healthy overweight/obese adults with major adverse cardiovascular events (MACE) and the effect of LDL-cholesterol levels on this association. This study was conducted with 15,904 participants from the URRAH study grouped according to BMI and metabolic status. Healthy metabolic status was identified with and without including LDL-cholesterol. The risk of MACE during 11.8 years of follow-up was evaluated with multivariable Cox regressions. Among the participants aged <70 years, high BMI was associated with an increased risk of MACE, whereas among the older subjects it was associated with lower risk. Compared to the group with normal weight/healthy metabolic status, the metabolically healthy participants aged <70 years who were overweight/obese had an increased risk of MACE with an adjusted hazard ratio of 3.81 (95% CI, 1.34–10.85, p = 0.012). However, when LDL-cholesterol < 130 mg/dL was included in the definition of healthy metabolic status, no increase in risk was found in the overweight/obese adults compared to the normal weight individuals (hazard ratio 0.70 (0.07–6.71, p = 0.75). The present data show that the risk of MACE is increased in metabolically healthy overweight/obese individuals identified according to standard criteria. However, when LDL-cholesterol is included in the definition, metabolically healthy individuals who are overweight/obese have no increase in risk.

APA, Harvard, Vancouver, ISO, and other styles

28

Bermudez, Valmore, Joselyn Rojas, Juan Salazar, et al. "Biochemical and clinical characterization of metabolic phenotypes: a cross-sectional study from Maracaibo city, Venezuela." F1000Research 7 (February 27, 2018): 230. http://dx.doi.org/10.12688/f1000research.13897.1.

Full text

Abstract:

Background:In 1980, Reuben Andresen observed that in certain individuals, obesity did not increase mortality, introducing an atypical phenotype called “healthy obese”. Other studies reported that 10-15 % of lean individuals presented insulin resistance, hyperglycemia and dyslipidemia. The objective of this study was to evaluate biochemical and clinical characteristics of metabolic phenotypes in Maracaibo city.Methods:A descriptive, cross-sectional study with a randomized multistage sampling was performed including 1226 non diabetic individuals from both sexes. For phenotype definition, the subjects were first classified according to their BMI into Normal-Weight, Overweight and Obese; then divided in metabolically healthy and unhealthy using a two-step analysis cluster. To evaluate the relationship with coronary risk, a multiple logistic regression model was performed.Results:In the studied population, 5.2% (n=64) corresponded to unhealthy lean subjects, and 17.4% (n=217) to healthy obese subjects. Metabolically unhealthy normal-weight (MUNW) phenotype was found in males in 53.3% in contrast to 51.3% of metabolically unhealthy obese (MUO) phenotype found in females. An association between metabolically unhealthy phenotypes and a higher risk of a coronary event was found, especially for obese individuals (MHO: OR=1.85 CI95%: 1.11-3.09; p=0.02 and MUO: OR=2.09 CI95%: 1.34-3.28; p<0.01).Conclusion:Individuals with atypical metabolic phenotypes exist in Maracaibo city. Related factors may include insulin resistance, basal glucose levels, and triglycerides levels. Lastly, cardiovascular risk exhibited by healthy obese individuals should be classified in categories of major coronary risk related to lean subjects.

APA, Harvard, Vancouver, ISO, and other styles

29

Kruger, Herculina Salome, Zelda De Lange-Loots, Iolanthé Marike Kruger, and Marlien Pieters. "The Metabolic Profiles of Metabolically Healthy Obese and Metabolically Unhealthy Obese South African Adults over 10 Years." International Journal of Environmental Research and Public Health 19, no. 9 (2022): 5061. http://dx.doi.org/10.3390/ijerph19095061.

Full text

Abstract:

Obesity is associated with an increased cardiometabolic risk, but some individuals maintain metabolically healthy obesity (MHO). The aims were to follow a cohort of black South African adults over a period of 10 years to determine the proportion of the group that maintained MHO over 10 years, and to compare the metabolic profiles of the metabolically healthy and metabolically unhealthy groups after the follow-up period. The participants were South African men (n = 275) and women (n = 642) from the North West province. The prevalence of obesity and the metabolic syndrome increased significantly. About half of the metabolically healthy obese (MHO) adults maintained MHO over 10 years, while 46% of the women and 43% of men became metabolically unhealthy overweight/obese (MUO) at the end of the study. The metabolic profiles of these MHO adults were similar to those of the metabolically healthy normal weight (MHNW) group in terms of most metabolic syndrome criteria, but they were more insulin resistant; their CRP, fibrinogen, and PAI-1act were higher and HDL-cholesterol was lower than the MHNW group. Although the metabolic profiles of the MUO group were less favourable than those of their counterparts, MHO is a transient state and is associated with increased cardiometabolic risk.

APA, Harvard, Vancouver, ISO, and other styles

30

Somi, Mohammd Hossein, Zeinab Nikniaz, Alireza Ostadrahimi, Amir Taher Eftekhar Sadat, and Elnaz Faramarzi. "Is normal body mass index a good indicator of metabolic health in Azar cohort population?" Journal of Cardiovascular and Thoracic Research 11, no. 1 (2019): 53–60. http://dx.doi.org/10.15171/jcvtr.2019.09.

Full text

Abstract:

Introduction: Metabolic syndrome (Mets) has become most important public health problem in the world. We examined the association between Mets and different cardiometabolic phenotype in Azar cohort population. Methods: In the present study, the data of 13099 subjects who participated in Azar cohort study were cross-sectionally analyzed. Mets was defined according to the National Cholesterol Education Program’s Adult Treatment Panel III report (ATPIII) criteria. Participants were categorized into four cardiometabolic phenotypes including metabolically healthy Lean (MHL), metabolically unhealthy lean (MUHL), metabolically healthy Obese (MHO), metabolically unhealthy obese (MUHO) according to BMI cut–off point (25 kg/m2 ), and the presence of Mets. Results: Totally, the prevalence of Mets was 33.20% with the higher prevalence in women (40.1%). About 46.7% of participants were MHO and 1.6% of them were MHL. In both genders, MUHL had the highest prevalence of hyperglycemia, hypertrigliceridemia, hypo-HDL-cholestrolemia and Frahmingham 10-year CVD risk. In both MUHL and MUHO phenotypes, hypertriglyceridemia (OR: 31.97 [95% CI: 22.31, 45.81] and OR: 20.28 [95% CI: 17.32, 23.75]) and hypo-HDL cholestrolemia (OR:27.97 [95% CI: 17.35, 45.09] and OR:11.0 [95% CI: 9.62, 12.58]) are the strongest predictor of incidence of Mets. Also, the results of multinominal regression analyses indicated that in all cardiometabolic phenotypes, Framingham 10- year CVD risks had the lowest power for predicting of Mets incidence. Conclusion: Based on the results, in addition to obese individuals, multiple metabolic abnormalities were seen in normal weight individuals and these subjects are even at higher risk of developing Mets compared with metabolically obese individuals. So, it seems that decision on initiation of lifestyle interventions should not be only based on the BMI; rather metabolic status seems to be even more important.

APA, Harvard, Vancouver, ISO, and other styles

31

Wang, Xiao-Li, Xiang-Yun Chang, Xiao-Xiao Tang, Zhi-Gang Chen, Ting Zhou, and Kan Sun. "Peripheral invariant natural killer T cell deficiency in metabolically unhealthy but normal weight versus metabolically healthy but obese individuals." Journal of International Medical Research 44, no. 6 (2016): 1272–82. http://dx.doi.org/10.1177/0300060516663778.

Full text

Abstract:

Objective To investigate the proportion of circulating invariant natural killer T (iNKT) cells in four body health types. Methods In this cross-sectional study, participants were classified into four body health types according to the body mass index and metabolic status: metabolically healthy and normal weight (MHNW), metabolically unhealthy but normal weight (MUNW), metabolically healthy but obese (MHO), or metabolically unhealthy and obese (MUO). Demographic and clinical characteristics were measured, and the homeostasis model assessment of insulin resistance (HOMA-IR) and visceral adiposity index (VAI) were calculated. The proportion of circulating iNKT cells was also evaluated by flow cytometry. Results The study enrolled 41 MHNW, 37 MUNW, 30 MHO, and 43 MUO participants. Compared with the MHNW group, the MUNW, MHO, and MUO groups had significantly lower iNKT cell proportions. The iNKT cell proportion was significantly higher in the MHO group than the MUNW and MUO groups. The iNKT cell proportion was inversely correlated with high-sensitivity C-reactive protein, HOMA-IR, and VAI values. Conclusion The proportion of iNKT cells was lower in people (lean or obese) with excessive visceral fat accumulation, suggesting that iNKT cell deficiency may be involved in the pathophysiology of obesity-related metabolic disorders.

APA, Harvard, Vancouver, ISO, and other styles

32

Sánchez-Iñigo, Laura, David Navarro-González, Alejandro Fernández-Montero, Juan Pastrana-Delgado, and JA Martínez. "Risk of incident ischemic stroke according to the metabolic health and obesity states in the Vascular-Metabolic CUN cohort." International Journal of Stroke 12, no. 2 (2016): 187–91. http://dx.doi.org/10.1177/1747493016672083.

Full text

Abstract:

Background Whether obesity is a major risk factor for cardiovascular disease in the absence of metabolic comorbidities remains under debate. Indeed, some obese individuals may be at low risk of metabolic-related complications, while normal-weight individuals may not be “healthy.” Aims To assess the incidence of ischemic stroke according to the metabolic health and obesity states of 5171 participants from the Vascular-Metabolic CUN cohort. Methods A Cox proportional-hazard analysis was conducted to estimate the hazard ratio and their 95% confidence interval of stroke according to the metabolic health and obesity states based on TyG index and Adult Treatment Panel-III criteria, during 9.1 years of follow-up. Results After 50,056.2 person-years of follow-up, 162 subjects developed an ischemic stroke (incidence rate 3.23 per 1000 person-years). Metabolically healthy obese subjects did not show greater risk of stroke, while metabolically unhealthy participants, obese and non-obese, had an increased risk of stroke, compared with healthy non-obese. The hazard ratios for the multivariable adjusted model were 1.55 (95% CI: 1.36–1.77) and 1.86 (95% CI: 1.57–2.21), respectively. Conclusions Metabolically unhealthy individuals exhibited a greater risk of ischemic stroke than metabolically healthy obese individuals.

APA, Harvard, Vancouver, ISO, and other styles

33

Rotar, O., A. Konradi, S. Shalnova, et al. "[OP.2A.03] METABOLICALLY HEALTHY OBESITY AND METABOLICALLY OBESE NORMAL WEIGHT IN RUSSIAN POPULATION." Journal of Hypertension 34 (September 2016): e16. http://dx.doi.org/10.1097/01.hjh.0000491368.63715.51.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Ding, W. Q., Y. K. Yan, M. X. Zhang, et al. "Hypertension outcomes in metabolically unhealthy normal-weight and metabolically healthy obese children and adolescents." Journal of Human Hypertension 29, no. 9 (2015): 548–54. http://dx.doi.org/10.1038/jhh.2014.124.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Mathew, Hannah, Olivia M. Farr, and Christos S. Mantzoros. "Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients." Metabolism 65, no. 1 (2016): 73–80. http://dx.doi.org/10.1016/j.metabol.2015.10.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Tang, Minhua, Qi Zhao, Kangqi Yi, et al. "Association between Metabolic Phenotypes of Body Fatness and Incident Stroke: A Prospective Cohort Study of Chinese Community Residents." Nutrients 14, no. 24 (2022): 5258. http://dx.doi.org/10.3390/nu14245258.

Full text

Abstract:

This study aimed to assess the association of body mass index (BMI)-based and waist circumference (WC)-based metabolic phenotypes with the risk of stroke among Chinese community residents. A total of 34,294 participants (mean ± standard deviation age: 56.05 ± 11.26 years) with no previous stroke diagnosis history were included in this cohort study. BMI-based metabolic phenotypes were classified into eight groups: metabolically healthy and normal weight (MHNW), metabolically healthy and underweight (MHUW), metabolically healthy and overweight (MHOW), metabolically healthy and obese (MHO), metabolically unhealthy and normal weight (MUNW), metabolically unhealthy and underweight (MUUW), metabolically unhealthy and overweight (MUOW), and metabolically unhealthy and obese (MUO). WC-based metabolic phenotypes were classified into four groups: metabolically healthy and normal WC (MHNWC), metabolically healthy and oversized WC (MHOWC), metabolically unhealthy and normal WC (MUNWC), and metabolically unhealthy and oversized WC (MUOWC). The association of these phenotypes with developing stroke events was examined using proportional hazards models. A total of 546 cases of first-stroke onset were recorded over a median follow-up time of 4.97 years. Compared with the reference group, the obesity phenotypes showed higher risks for stroke. The adjusted HRs (95% CIs) of MHUW, MHOW, MHO, MUNW, MUUW, MUOW, and MUO phenotypes were 1.01 (0.41, 2.49), 1.47 (1.09, 2.00), 1.33 (0.80, 2.22), 2.49 (1.87, 3.30), 3.92 (1.44, 10.72), 2.14 (1.64, 2.79), and 2.60 (1.91, 3.55), respectively. The adjusted HRs (95% CIs) of MHOWC, MUNWC, and MUOWC were 1.41 (1.02, 1.94), 2.25 (1.76, 2.87), and 2.16 (1.63, 2.87), respectively. The metabolic phenotypes defined by an alternative definition all showed significant positive associations (except for MHUW), with the adjusted HR ranging from 1.51 to 3.08 based on BMI and from 1.68 to 2.24 based on WC. The risk of stroke increased with the increase in metabolic abnormality numbers in different BMI and WC groups (all p trend < 0.001). The present study suggests that maintaining normal body weight or WC and improving metabolic health are of great significance in preventing cerebrovascular diseases.

APA, Harvard, Vancouver, ISO, and other styles

37

Zhang, Yan, Jing Fu, Shuwen Yang, et al. "Prevalence of metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) in Chinese Beijing urban subjects." BioScience Trends 11, no. 4 (2017): 418–26. http://dx.doi.org/10.5582/bst.2017.01016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Bonikowske, Amanda R., Maria Irene Barillas Lara, Katlyn E. Koepp, et al. "Fat Mass Index Better Identifies Metabolic Syndrome: Insights from Patients in Early Outpatient Cardiac Rehabilitation." Journal of Clinical Medicine 8, no. 12 (2019): 2147. http://dx.doi.org/10.3390/jcm8122147.

Full text

Abstract:

Body mass index (BMI) does not differentiate fat and lean mass or the distribution of adipose tissue. The purpose of this study was to examine the prevalence of metabolic syndrome (MetS) among patients entering outpatient cardiac rehabilitation (CR) across fat mass index (FMI) categories compared with BMI. This retrospective cross-sectional study evaluated dual-energy x-ray absorptiometry in 483 CR patients from 1 January 2014, through 31 December 2017. Clinical data were extracted from the electronic health record. Patients were grouped by FMI and BMI categories. Mean (SD) age of patients was 64.3 (14) years. The normal FMI category had 15 patients; excess fat, 74; and obese, 384. In contrast, 93, 174, and 216 were in the normal, overweight, and obese BMI categories, respectively. Prevalence of MetS was 0 (0%) in normal, 5 (1%) in excess fat, and 167 (54%) in obese FMI, with 97% in the obese category. MetS prevalence was 4 patients (0.8%) in normal, 39 (8%) in overweight, and 129 (27%) in obese BMI categories, with 75% of MetS in the obese category. FMI more accurately classified CR patients with metabolically abnormal fat (p < 0.001). FMI is a more sensitive index than BMI for metabolically abnormal fat of outpatient CR patients.

APA, Harvard, Vancouver, ISO, and other styles

39

Sultana, Sharmin, Md Matiur Rahman, Rinky Rani Saha, Md Golam Ahad, Jakia Sultana Shila, and Md Aminul Haque Khan. "Microalbuminuria in Metabolic Obesity: A Cross-Sectional Study in a Selected Tertiary Care Hospital of Bangladesh." Journal of Enam Medical College 10, no. 3 (2022): 159–68. http://dx.doi.org/10.3329/jemc.v10i3.59357.

Full text

Abstract:

Background: Overweight and obese individuals may have no cardiometabolic risk whereas normal weight individuals may present with cardiometabolic risk. The term‘Metabolic obesity’ has been floated to identify hidden metabolic risks irrespective of BMI. The pathophysiology of metabolic obesity can be explained by microvascular dysfunction and microalbuminuria is a wellknown marker of microvascular dysfunction. Objective: The objective of this study was to find out the association of microalbuminuria with metabolic obesity in Bangladeshi adult subjects. Materials and Methods: This cross- sectional analytical study included 200 individuals who attended outpatient department in Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka from March 2018 to February 2019. The study subjects were divided into metabolically obese (metabolically unhealthy) group and metabolically non-obese (metabolically healthy) group by metabolic syndrome (MetS) criteria. Metabolic syndrome was defined according to the South Asian Modified-National Cholesterol Education Program (NCEP). Microalbuminuria was defined as a urinary albumin to creatinine of 30 to 300 mg/gm. Demographic profile, BP, height, weight, waist circumference etc. were measured and fasting blood glucose, serum triglyceride, serum HDL-C were estimated and albumin to creatinine ratio (ACR) was calculated. Statistical analysis was done using SPSS version 22.0. Results: The frequencies of metabolically obese (metabolically unhealthy) group and metabolically non-obese (metabolically healthy) group were 128 (64%) and 72 (36%) respectively. Mean values for age (p value 0.001), body mass index (p value 0.027), waist circumference (p<0.001), systolic blood pressure (SBP) (p<0.001) and diastolic blood pressure (DBP) (p<0.001), fasting blood glucose (p<0.001) and triglycerides (p<0.001) were significantly higher in the metabolically obese group compared to metabolically non-obese group. Among the study subjects, the prevalence of microalbuminuria was 32.5% and prevalence of microalbuminuria was found very high (38.3%) in metabolically obese group, whereas microalbuminuria in metabolically non-obese group was found 22.2%, which was statistically significant (p value 0.02). Our results showed that diastolic BP (p<0.001), systolic BP (p<0.001), fasting blood sugar (p<0.001) and triglyceride (p<0.008) were significantly correlated with microalbuminuria. In the logistic regression analysis, diastolic BP (p value 0.015) and FBS (p value 0.039) were significantly associated with microalbuminuria. After harmonization of statistical analysis, our study indicated that elevated blood pressure and fasting blood sugar had strong association with microalbuminuria and are likely to be critical components that lead a substantial number of subjects to the prestage of metabolic obesity in the Bangladeshi adult population. Conclusion: Our study concludes that the prevalence of microalbuminuria is significantly high in metabolic obesity (metabolically unhealthy) in Bangladeshi adult population. Association of microalbuminuria with metabolic obesity is mainly attributed to high diastolic blood pressure and fasting blood glucose. J Enam Med Col 2020; 10(3): 159-168

APA, Harvard, Vancouver, ISO, and other styles

40

Garrido-Acosta, Osvaldo, Brisa Oro-López, Nathalie Molina-López, Adriana Altamirano-Bautista, and Adelfo Reyes-Ramírez. "Development of Metabolically Obese but Normal Weight (MONW) Wistar Rats by Oral Administration of Hypercaloric Emulsion." Pharmaceutical and Chemical Journal 5, no. 5 (2018): 15–22. https://doi.org/10.5281/zenodo.13923891.

Full text

Abstract:

Obesity is defined as the accumulation of adipose tissue, overweight and obesity are defined on the basis of body mass index and this is accompanied by an increased prevalence of comorbidities as type 2 diabetes, cardiovascular and metabolic disease in the population. The standard relationship between weight status and metabolic health is not applicable for some subtypes of individuals, the subtypes are known as “metabolically obese, but normal-weight”, and others are the “metabolically healthy, but obese” phenotypes. Regarding the problem of obesity there are areas of progress, greater social and political awareness, development of new treatments, and an extended base of evidence for its prevention and intervention. In contrast, the prevalence of this has increased rapidly in the last two decades, largely to the lifestyle of large cities. For the study of overweight, obesity and its physiopathology consequences, in addition to clinical studies in humans, are used animal models for understand the evolution of disease and support the development of therapies, the animal models, the current animal models generate rats with phenotype metabolically obese with overweight. In this research we proposed to evaluate the effect of intragastric administration of a hypercaloric emulsion composed of fructose syrup and edible vegetable oil on development of obesity in rats, we obtained rats with phenotype metabolically healthy but obesity only in eight weeks with adiposity index of 11.5 vs 5.9 of control group and 8.3 on sham group with fructose drinking solution.  

APA, Harvard, Vancouver, ISO, and other styles

41

Lentzas, I., V. Garmiri, A. Katsanaki, et al. "Abstract: P1303 METABOLICALLY OBESE PATIENTS WITH NORMAL WEIGHT HAVE GREATER DEGREE OF CARDIOVASCULAR RISKS THAN METABOLICALLY HEALTHY BUT OBESE PATIENTS." Atherosclerosis Supplements 10, no. 2 (2009): e1359. http://dx.doi.org/10.1016/s1567-5688(09)71320-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Narankiewicz, Dariusz, Josefina Ruiz-Nava, Veronica Buonaiuto, et al. "Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population." International Journal of Environmental Research and Public Health 17, no. 10 (2020): 3518. http://dx.doi.org/10.3390/ijerph17103518.

Full text

Abstract:

The aim of this study was to analyze the utility of liver function tests (LFT) and fatty liver index (FLI), a surrogate marker of non-alcoholic fatty liver disease, in the categorization of metabolic phenotypes in a Mediterranean population. A cross-sectional study was performed on a random representative sample of 2233 adults assigned to a health center in Málaga, Spain. The metabolic phenotypes were determined based on body mass index (BMI) categorization and the presence or absence of two or more cardiometabolic abnormalities (high blood pressure, low high-density lipoprotein (HDL) cholesterol, hypertriglyceridemia, pre-diabetes) or type 2 diabetes. No difference was observed between metabolically healthy and metabolically abnormal phenotypes on LFT. The mean FLI of the population was 41.1 ± 28.6. FLI was significantly higher (p < 0.001) in the metabolically abnormal phenotypes in all BMI categories. The proportion of individuals with pathological FLI (≥60) was significantly higher in the metabolically abnormal overweight and obese phenotypes (p < 0.001). On a multivariate model adjusted for sex, age, and waist circumference, a significant correlation was found between pathological FLI and metabolically abnormal phenotypes in the overweight and obese BMI categories. Area under the curve (AUC) of FLI as a biomarker was 0.76, 0.74, and 0.72 for the metabolically abnormal normal-weight, overweight, and obese groups, respectively. Liver biochemistry is poorly correlated with metabolic phenotypes. Conversely, a good correlation between FLI, as a marker of non-alcoholic fatty liver disease (NAFLD), and metabolically abnormal phenotypes in all BMI ranges was found. Our study suggests that FLI may be a useful marker for characterizing metabolically abnormal phenotypes in individuals who are overweight or obese.

APA, Harvard, Vancouver, ISO, and other styles

43

Chulkov, V. S., E. S. Gavrilova, V. S. Chulkov, E. D. Pankova, S. A. Martynov, and V. I. Manzhos. "Cardiometabolic risk factors and renin-angiotensin system polymorphisms in young individuals with various metabolic phenotypes." "Arterial’naya Gipertenziya" ("Arterial Hypertension") 28, no. 1 (2022): 58–66. http://dx.doi.org/10.18705/1607-419x-2022-28-1-58-66.

Full text

Abstract:

Background. The increased prevalence of obesity and associated cardiometabolic diseases attract attention worldwide. Renin-angiotensin system can link obesity and cardiovascular and metabolic diseases.Objective. To access a comprehensive assessment of cardiometabolic risk factors and gene polymorphisms of the renin-angiotensin system in metabolic phenotypes among young individuals.Design and methods. The sample consisted of 251 individuals, who were divided into four groups: group 1 — metabolically healthy individuals with normal body mass index (BMI) (n = 62); group 2 — metabolically unhealthy individuals with normal BMI (n = 57); group 3 — metabolically healthy overweight/obese individuals (n = 16); group 4— metabolically unhealthy overweight/ obese individuals (n = 116). All participants answered a questionnaire designed for this study. Anthropometric, clinical and biochemical parameters were assessed. The following polymorphisms were evaluated:, A1166C polymorphism of the angiotensin II type 1 receptor gene (rs5186), M235T polymorphism of the angiotensinogen gene (rs699), T174M polymorphism of the angiotensinogen gene (rs4762), I/D polymorphism of the angiotensinconverting enzyme gene (rs4340).Results. In young individuals with metabolically unhealthy overweight/ obesity, a higher frequency of coexistent abdominal obesity and hypertension was found in combination with a higher frequency of the allele T of AGT 235M/T. The greater differences in carbohydrate and lipid metabolism in combination with a higher serum levels of leptin and low serum concentrations of adiponectin were also found in young individuals with metabolically unhealthy overweight/obesity.

APA, Harvard, Vancouver, ISO, and other styles

44

Pacifico, Lucia, Eleonora Poggiogalle, Francesco Costantino, et al. "Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome." European Journal of Endocrinology 161, no. 6 (2009): 861–70. http://dx.doi.org/10.1530/eje-09-0375.

Full text

Abstract:

BackgroundGhrelin, a peptide mainly derived from the stomach, plays a pivotal role in the regulation of food intake, energy metabolism, and storage, as well as in insulin sensitivity. Ghrelin circulates in acylated (A-Ghr) and nonacylated (NA-Ghr) forms, and their potential differential associations with insulin resistance (IR) in childhood obesity remain undefined.ObjectiveWe investigated the associations of ghrelin forms with IR in normal weight and obese children and the impact of metabolic syndrome (MS) on their plasma values.DesignA total of 210 children in four subgroups of normal weight/obese children with and without components of MS were studied. Fasting blood glucose, insulin, lipid profile, and acylated and total ghrelin were examined. IR was determined by a homeostasis model assessment (HOMA) of IR.ResultsIn the entire population, plasma insulin and HOMA-IR were associated negatively with T-Ghr and NA-Ghr, but positively with the ratio of A/NA-Ghr after adjustment for age, gender, and Tanner stage. Obese metabolically abnormal children had lower T-Ghr and NA-Ghr, but comparable A-Ghr and a higher A/NA-Ghr ratio than obese metabolically normal subjects. Compared with lean healthy children, lean metabolically abnormal subjects had higher A-Ghr and the A/NA-Ghr ratio, but comparable T-Ghr and NA-Ghr. A multiple regression analysis showed that A-Ghr and the A/NA-Ghr ratios were positively associated with HOMA-IR, independent of age, gender, Tanner stage, and body mass index (or waist circumference) and other components of MS.ConclusionsA-Ghr excess may negatively modulate insulin action in obese and nonobese children, and may contribute to the association of IR and MS.

APA, Harvard, Vancouver, ISO, and other styles

45

Faienza, Maria Felicia, Flavia Urbano, Giuseppe Lassandro, et al. "The Cardiovascular Disease (CVD) Risk Continuum from Prenatal Life to Adulthood: A Literature Review." International Journal of Environmental Research and Public Health 19, no. 14 (2022): 8282. http://dx.doi.org/10.3390/ijerph19148282.

Full text

Abstract:

The risk of developing cardiovascular diseases (CVDs) arises from the interaction of prenatal factors; epigenetic regulation; neonatal factors; and factors that affect childhood and adolescence, such as early adiposity rebound (AR) and social and environmental influences. Thus, CVD risk varies between the group of low-risk metabolically healthy normal-weight subjects (MHNW); the intermediate-risk group, which includes metabolically healthy obese (MHO) and metabolically unhealthy normal-weight subjects (MUHNW); and the high-risk group of metabolically unhealthy obese (MUHO) subjects. In this continuum, several risk factors come into play and contribute to endothelial damage, vascular and myocardial remodeling, and atherosclerotic processes. These pathologies can occur both in prenatal life and in early childhood and contribute to significantly increasing CVD risk in young adults over time. Early intervention in the pediatric MUHO population to reduce the CVD risk during adulthood remains a challenge. In this review, we focus on CVD risk factors arising at different stages of life by performing a search of the recent literature. It is urgent to focus on preventive or early therapeutic strategies to stop this disturbing negative metabolic trend, which manifests as a continuum from prenatal life to adulthood.

APA, Harvard, Vancouver, ISO, and other styles

46

Twig, Gilad, Hertzel C. Gerstein, Dana Ben-Ami Shor, et al. "Coronary artery disease risk among obese metabolically healthy young men." European Journal of Endocrinology 173, no. 3 (2015): 305–12. http://dx.doi.org/10.1530/eje-15-0284.

Full text

Abstract:

ObjectiveThe aim of this study was to assess coronary artery disease (CAD) risk among obese young men without metabolic risk factors.DesignA longitudinal study in a historical cohort.MethodsIncident CAD during a median follow-up of 6.1 years was assessed among 31 684 young men (mean age 31.2±5.7 years) of the Metabolic, Lifestyle and Nutrition Assessment in Young Adults (MELANY) cohort. Participants were categorized by BMI and the number of metabolic abnormalities (based on the Adult Treatment Panel-III). Metabolically healthy (MH) obesity was defined as BMI ≥30 kg/m2 in the presence of normal blood pressure (BP) and normal levels of fasting glucose, triglyceride, and HDL-cholesterol (HDL-c) levels (n=599; 1.9%). Cox proportional hazard models were applied.ResultsThere were 198 new cases of CAD that were diagnosed during 209 971 person-years of follow-up, of which six cases occurred among MH obese. The incidence of CAD among MH lean, overweight, and obese participants was 0.23, 0.45, and 1.0/1000 person-years respectively. In a multivariable model adjusted for clinical and biochemical CAD risk factors, a higher CAD risk was observed among MH-obese (hazard ratio=3.08; 95% CI=1.10–8.68, P=0.033), compared to MH-normal weight subjects. This risk persisted when BMI was treated as a time-dependent variable, or when fasting glucose, HDL-c, triglycerides, or BP were added to the model. Similar results were also obtained when a more permissive definition of MH was used.ConclusionsObesity may continue to contribute to increased risk for incident CAD in young men even in the presence of a healthy metabolic profile.

APA, Harvard, Vancouver, ISO, and other styles

47

Yoo, Hye Jin. "Pathogenesis and Clinical Implications of Metabolically Healthy Obesity (MHO) and Metabolically Obese Normal Weight (MONW) Subjects." Journal of Korean Diabetes 15, no. 1 (2014): 12. http://dx.doi.org/10.4093/jkd.2014.15.1.12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Mintoff, Dillon, Rachel Agius, Stephen Fava, and Nikolai P. Pace. "Investigating Adiposity-Related Metabolic Health Phenotypes in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study." Journal of Clinical Medicine 12, no. 14 (2023): 4847. http://dx.doi.org/10.3390/jcm12144847.

Full text

Abstract:

Background: Obesity and hidradenitis suppurativa (HS) are related through meta-inflammation and are both associated with increased cardiometabolic risk. Notwithstanding, cardiometabolic pathology is not uniform in obesity and a subset of individuals with excess adiposity exhibit a healthy metabolic profile. Whilst the incidence of cardiometabolic endpoints and transitions across different adiposity-related body composition phenotypes within several populations and across different ethnicities have been investigated, data regarding metabolic health (MetH) and body composition phenotypes in individuals with HS are lacking. The objective of this study was to evaluate the relationship between different body composition phenotypes in individuals with HS. Methods: This was a cross-sectional study of 632 individuals with and without HS from a population with a high prevalence of both obesity and HS. A total of four body composition phenotypes were generated based on BMI and metabolic status (defined using either the metabolic syndrome definition or the homeostasis model of insulin resistance (HOMA-IR)): metabolically healthy overweight/obese (MHOWOB), metabolically unhealthy overweight/obese (MUOWOB), metabolically healthy normal weight (MHNW), and metabolically unhealthy normal weight (MUNW). Results: Generally, subjects with HS exhibited a worse metabolic profile with higher levels of indices of central adiposity measures (including Visceral Adiposity Index and waist circumference), systolic blood pressure and markers of insulin resistance, as well as a higher prevalence of the metabolic syndrome. Moreover, when sub-stratified into the different body composition phenotypes, individuals with HS typically also demonstrated adverse metabolic characteristics relative to controls matched for both adiposity and metabolic health, particularly in the normal weight category and despite being classified as metabolically healthy. Being metabolically unhealthy in addition to being overweight/obese increases an individual’s risk of HS. Conclusions: Metabolic risk-assessment should be prioritized in the clinical management of individuals with HS even in those who are lean. Patients attending HS clinics provide a valuable opportunity for targeted cardiovascular risk reduction with respect to the management of both obesity and metabolic health.

APA, Harvard, Vancouver, ISO, and other styles

49

Korac, Aleksandra, Biljana Srdic-Galic, Ana Stancic, Vesna Otasevic, Bato Korac, and Aleksandra Jankovic. "Adipokine signatures of subcutaneous and visceral abdominal fat in normal-weight and obese women with different metabolic profiles." Archives of Medical Science 17, no. 2 (2021): 323–36. http://dx.doi.org/10.5114/aoms/92118.

Full text

Abstract:

IntroductionMetabolic syndrome arises from abnormal adipose function accompanied by insulin resistance. As early factors reflecting/impacting lipid storage dysfunction of adipose tissues, we sought to determine adipokine levels in subcutaneous and visceral adipose tissues (SAT and VAT).Material and methodsGene and protein expression of leptin, adiponectin, and resistin were analyzed in SAT and VAT of normal-weight and overweight/obese women, subclassified according to insulin resistance index, triglyceride, total-, LDL- and HDL-cholesterol levels into metabolically healthy and “at risk” groups.ResultsCompared with normal-weight women, obese women had higher serum leptin levels (P<0.05), as well as increased leptin gene and protein expression in VAT. Conversely, expression levels of leptin were lower in SAT of obese women, and minor in the SAT of “at risk” groups of women, compared with weight-matched healthy groups. In addition, lower adiponectin levels were detected in SAT of metabolically healthy obese women (P<0.01), and lower in SAT and VAT (P<0.05) of “at risk” obese women compared to healthy, obese women. Significant differences in resistin levels were only observed in obese women; resistin gene expression was higher in VAT and SAT of obese, compared to normal-weight women. However, higher gene expression was not consistent with protein expression of resistin.ConclusionsLow adiponectin in both examined adipose tissues and inappropriate leptin expression levels in SAT appear to be important characteristics of obesity-related metabolic syndrome. Intriguingly, this adipokine dysregulation is primary seen in SAT, suggesting that endocrine dysfunction in this abdominal depot may be an early risk sign of metabolic syndrome.

APA, Harvard, Vancouver, ISO, and other styles

50

Kim, Jae-Woo, Do Hoon Kim, Yong Kyun Roh, et al. "Serum Ferritin Levels Are Positively Associated With Metabolically Obese Normal Weight." Medicine 94, no. 52 (2015): e2335. http://dx.doi.org/10.1097/md.0000000000002335.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'And metabolically normal obese'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles